 |
Allergan launches new injectable treatment to improve skinAllergan, a leading global biopharmaceutical company, has launched its new injectable treatment designed to improve skin quality and lasts up to nine months with just one treatment session. The treatment uses the unique patented V More… |
 |
Pfizer Q1 revenue soars 19.7pcUS drugmaker Pfizer reported first-quarter revenue that blew past analysts' average estimate, boosted by sales of its new treatments for cancer and its Hospira acquisition. Shares of the company were up 3.2 per cent at $33.86 More… |
 |
Obama's inversion curbs kill Pfizer's $160bn Allergan dealUS drug maker Pfizer Inc agreed on Tuesday to terminate its $160 billion agreement to acquire Botox maker Allergan Plc, in a major victory to US President Barack Obama's drive to stop tax-dodging corporate mergers. The decisio More… |
 |
Pfizer, Allergan to terminate mergerDrugmakers Pfizer Inc and Allergan Plc will mutually terminate their merger early Wednesday morning, according to a source familiar with the matter. Earlier on Tuesday, Reuters reported that Pfizer was leaning towards abandoning i More… |
 |
Teva divesting $1bn in assets to clear Allergan dealTeva Pharmaceutical Industries Ltd is in the process of divesting about $1 billion worth of assets to address antitrust concerns over its deal to buy Allergan Plc's generic drugs business, people familiar with the matter said. More… |
|
Teva divesting $1bn in assets to clear Allergan dealTeva Pharmaceutical Industries Ltd is in the process of divesting about $1 billion worth of assets to address antitrust concerns over its deal to buy Allergan Plc's generic drugs business, people familiar with the matter said. More… |
 |
Pfizer to buy Allergan in $160bn dealPfizer, the maker of Viagra and Lipitor, has struck a deal to buy Botox-maker Allergan in a transaction valued at about $160 billion, creating the world's biggest drugmaker. New York-based Pfizer and Allergan, headquartered in More… |
|
Pfizer to buy Allergan in $160bn dealPfizer, the maker of Viagra and Lipitor, has struck a deal to buy Botox-maker Allergan in a transaction valued at about $160 billion, creating the world's biggest drugmaker. New York-based Pfizer and Allergan, headquartered in More… |
|
Pfizer set to buy Botox maker Allergan for $150bnPfizer was due to secure formal board approval on Sunday for its acquisition of Botox maker Allergan for more than $150 billion, making it the healthcare sector's largest deal ever, according to people familiar with the matter. More… |
 |
Pfizer in talks with Allergan to forge $330bn drugs giantPharmaceutical giant Pfizer Inc has held early talks with Botox-maker Allergan to discuss what could be the biggest takeover deal this year, the Wall Street Journal and Financial Times reported. The healthcare sector has seen an u More… |
